MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression.

Ye Y, Zhuang J, Wang G, He S, Ni J, Xia W

DOI: 10.3892/ol.2017.7201
Published: 2017 Dec
Container: Oncology letters
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3892/ol.2017.7201,
  title = {MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression.},
  author = {Ye Y and Zhuang J and Wang G and He S and Ni J and Xia W},
  year = {2017},
  journal = {Oncology letters},
  doi = {10.3892/ol.2017.7201},
  url = {https://doi.org/10.3892/ol.2017.7201}
}

RIS

TY  - JOUR
TI  - MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression.
AU  - Ye Y
AU  - Zhuang J
AU  - Wang G
AU  - He S
AU  - Ni J
AU  - Xia W
PY  - 2017
JO  - Oncology letters
DO  - 10.3892/ol.2017.7201
UR  - https://doi.org/10.3892/ol.2017.7201
ER  -

APA

Y, Y., J, Z., G, W., S, H., J, N., & W, X. (2017). MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression.. Oncology letters. https://doi.org/10.3892/ol.2017.7201

Source records

pubmed · retrieved 2026-09-24T19:46:59.560Z